SKI Market

Indian Indices

Nifty

25,898.55 140.55
(0.55%)

Sensex

84,818.13 426.86
( 0.51%)

Bank Nifty

59,209.85 249.45
( 0.42%)

Nifty IT

38,097.00 307.10
( 0.81%)

Global Indices

Nasdaq

48,074.52 493.22
(1.04%)

Dow Jones

6,906.36 44.85
(0.65%)

Hang Seng

50,166.54 -436.26
(-0.86%)

Nikkei 225

9,661.39 19.38
(0.20%)

Forex

USD-INR

89.93 -0.16
(-0.18%)

EUR-INR

104.64 -0.26
(-0.25%)

GBP-INR

119.76 -0.28
(-0.23%)

JPY-INR

0.58 0.00
(-0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

42.05

830.54

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.21

Back

Modulex Construction Technologies reports consolidated net loss of Rs 4.12 crore in the June 2025 quarter

Aug 12,2025

Net loss of Modulex Construction Technologies reported to Rs 4.12 crore in the quarter ended June 2025 as against net profit of Rs 11.17 crore during the previous quarter ended June 2024. There were no Sales reported in the quarter ended June 2025 and during the previous quarter ended June 2024.

25,898.55 140.55 (0.55%)

84,818.13 426.86 ( 0.51%)

59,209.85 249.45 ( 0.42%)

38,097.00 307.10 ( 0.81%)

48,074.52 493.22 (1.04%)

6,906.36 44.85 (0.65%)

50,166.54 -436.26 (-0.86%)

9,661.39 19.38 (0.20%)

89.93 -0.16 (-0.18%)

104.64 -0.26 (-0.25%)

119.76 -0.28 (-0.23%)

0.58 0.00 (-0.73%)